In the present study, we found that the increment of CD31+/CD41a− EMPs and PMPs after injection of iohexol was more in patients with DM than in those without DM, which indicates that diabetes patients are more sensitive to iohexol. The gene discussed is PECAM1; the disease is diabetes mellitus.